Aterian, Inc. (NASDAQ:ATER – Get Free Report)’s stock price fell 3.8% during mid-day trading on Monday . The stock traded as low as $1.24 and last traded at $1.25. 106,227 shares were traded during mid-day trading, a decline of 35% from the average daily volume of 164,060 shares. The stock had previously closed at $1.30.
Wall Street Analysts Forecast Growth
ATER has been the subject of a number of analyst reports. Wall Street Zen upgraded Aterian to a “hold” rating in a research note on Saturday, June 27th. Weiss Ratings raised shares of Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, May 19th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.
Check Out Our Latest Analysis on ATER
Aterian Stock Down 3.8%
Aterian (NASDAQ:ATER – Get Free Report) last released its quarterly earnings results on Friday, May 15th. The company reported ($0.39) EPS for the quarter, beating analysts’ consensus estimates of ($0.69) by $0.30. Aterian had a negative net margin of 39.56% and a negative return on equity of 82.05%. The firm had revenue of $0.02 million during the quarter, compared to analyst estimates of $15.82 million.
Institutional Trading of Aterian
A number of hedge funds have recently made changes to their positions in ATER. Citadel Advisors LLC boosted its holdings in shares of Aterian by 222.0% in the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after purchasing an additional 22,865 shares in the last quarter. Susquehanna International Group LLP boosted its stake in shares of Aterian by 310.2% during the third quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after purchasing an additional 30,637 shares during the period. Goldman Sachs Group Inc. boosted its position in Aterian by 73.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after buying an additional 9,026 shares during the period. Finally, XTX Topco Ltd purchased a new stake in shares of Aterian during the second quarter worth about $55,000. 7.02% of the stock is owned by institutional investors.
About Aterian
Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.
Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.
See Also
- Five stocks we like better than Aterian
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.
